Psychopharmacology explores the effects of drugs on the human mind and behavior, with a focus on pharmacodynamics—the study of how drugs interact with the body. In this field, researchers investigate the mechanisms by which psychoactive substances exert their influence on the central nervous system. Pharmacodynamics delves into the drug-receptor interactions, signal transduction pathways, and molecular alterations that underlie the physiological and psychological responses to medications. Understanding pharmacodynamics is crucial in tailoring drug therapies for mental health disorders, as it helps elucidate the specific targets and modes of action that contribute to therapeutic effects or potential side effects. Researchers in psychopharmacology strive to unravel the intricate relationships between drugs and neural processes, aiming to enhance the precision and efficacy of pharmacological interventions for conditions like depression, anxiety, and psychosis. As the field evolves, a deeper comprehension of pharmacodynamics promises to pave the way for more targeted and personalized approaches to mental health treatment.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia